Asset Allocation

As of December 31, 2025.
Type % Net
Cash 29.77%
Stock 36.96%
Bond 33.27%
Convertible 0.00%
Preferred 0.00%
Other 0.00%
View Asset Allocation
Start Trial

Market Capitalization

As of December 31, 2025
Large 84.39%
Mid 11.10%
Small 4.51%
View Market Capitalization
Start Trial

Region Exposure

% Developed Markets: 63.83%    % Emerging Markets: 6.40%    % Unidentified Markets: 29.77%

Americas 41.30%
34.90%
United States 34.90%
6.40%
Argentina 1.53%
Colombia 1.09%
Mexico 3.78%
As of December 31, 2025. Region breakdown data is calculated by using the long position holdings of the portfolio.
Greater Europe 16.41%
United Kingdom 2.69%
13.72%
France 2.82%
Netherlands 1.10%
Norway 2.45%
Sweden 4.44%
Switzerland 2.91%
0.00%
0.00%
Greater Asia 12.51%
Japan 2.85%
7.76%
Australia 7.76%
1.91%
South Korea 1.91%
0.00%
Unidentified Region 29.77%

Bond Credit Quality Exposure

AAA 6.34%
AA 24.31%
A 11.95%
BBB 37.86%
BB 13.67%
B 0.00%
Below B 4.60%
    CCC 4.60%
    CC 0.00%
    C 0.00%
    DDD 0.00%
    DD 0.00%
    D 0.00%
Not Rated 1.27%
Not Available 0.00%
Short Term 0.00%
As of December 31, 2025
View Bond Credit Quality Exposure
Start Trial

Stock Sector Exposure

Cyclical
42.85%
Materials
22.54%
Consumer Discretionary
0.00%
Financials
20.31%
Real Estate
0.00%
Sensitive
35.91%
Communication Services
27.12%
Energy
0.00%
Industrials
0.00%
Information Technology
8.79%
Defensive
21.24%
Consumer Staples
6.09%
Health Care
15.15%
Utilities
0.00%
Not Classified
0.00%
Non Classified Equity
0.00%
Not Classified - Non Equity
0.00%
As of December 31, 2025
View Region Exposure
Start Trial

Bond Sector Exposure

As of December 31, 2025
Type % Net
Government 21.05%
Corporate 54.43%
Securitized 0.00%
Municipal 13.75%
Other 10.76%
View Bond Sector Exposure
Start Trial

Bond Maturity Exposure

Short Term
6.37%
Less than 1 Year
6.37%
Intermediate
35.56%
1 to 3 Years
3.27%
3 to 5 Years
25.21%
5 to 10 Years
7.08%
Long Term
58.07%
10 to 20 Years
26.10%
20 to 30 Years
13.04%
Over 30 Years
18.92%
Other
0.00%
As of December 31, 2025
View Bond Maturity Exposure
Start Trial